ZC3H12A and neoplasm: Regnase-1-deficient CAR-T cells1. ACT (transfer of Regnase-1-deficient CAR-T cells into tumor models);2. Enhanced tumor clearance;3. CAR-T cells showed the features of Tpex and long-term persistence in TME;